Whither Progress in the Diabetic Foot—Clinical and Research?

International Journal of Lower Extremity Wounds

Volumn 3, Issue 4, 2004, Pages 182-183

  Boulton, Andrew J M ^a   Armstrong, David G ^b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84993690295     PISSN: 15347346     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534734604271961     Document Type: Editorial

References (23)

1. van Houtum WH, Bakker K, eds. The diabetic foot: proceeding of the fourth international symposium on the diabetic foot. Diabetes Metab Res Rev 2004; 20(suppl 1): S1-S96.
2. Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet 2003; 361: 1545-1551.
3. Boulton AJM, Kirsner RS, Vileikyte L. Neuropathic diabetic foot ulceration. N Engl J Med 2004; 351: 44-51.
4. Boulton AJM. International collaboration on the diabetic foot: a fifteen year progress report. Diabetes Metab Res Rev 2004; 20(suppl 1):S2-S4.
5. Bakker K. Introduction to the consensus process. Diabetes Metab Res Rev 2004; 20(suppl 1):S65-S68.
6. Larsson J, Apelqvist J, Agardh CD, Stanstrom A. Decreasing incidence of major amputation in diabetic patients: a consequence of multidisciplinary team approach? Diabet Med 1995; 12: 770-776.
7. van Houtum WH, Rauwerda JA, Ruwaard D, Schaper NC, Bakker K. Reduction in diabetes-related lower extremity amputations in the Netherlands. 1991-2000. Diabetes Care 2004; 27: 1042-1046.
8. Rayman G, Krishman ST, Baker NR, Wareham AM, Rayman A. Are we understanding diabetes-related lower extremity amputation rates? Results and benefits of the first prospective study. Diabetes Care 2004; 27: 1892-1896.
9. Boulton AJM. The diabetic foot: from art to science. Diabetologia 2004; 47: 1343-1353.
10. Oyibo SO, Jude EB, Tarawneh I, Nguyentle, Harkless LA, Boulton AJM. A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas classifications. Diabetes Care 2001; 24: 86-88.
11. Treece KA, MacFarlane RM, Pound N, Game FL, Jeffcoate WJ. Validation of a system of foot ulcer classification in diabetes mellitus. Diabet Med 2004; 21: 987-991.
12. Jeffcoate WJ, Lipsky BA. Controversies in the diagnosis and management of osteomyelitis of the foot in diabetes. Clin Infect Dis 2004; 39(suppl 2):S115-S122.
13. Pedrosa HC, Leme LAP, Novaes C, et al. The diabetic foot in South America: progress with the Brazilian Save the Diabetic Foot Project. Int Diabet Monitor 2004; 16(4):17-24.
14. Morbach S, Lutale JK, Viswanathan V, et al. Regional differences in the risk factors and clinical presentation of diabetic foot lesions. Diabet Med 2004; 21: 91-95.
15. Jeffcoate WJ, Price P, Harding KG. Wound healing and treatments for people with diabetic foot ulcers. Diabetes Metab Res Rev 2004; 20(suppl 1):S78-S89.
16. Piaggesi A, Viacava P, Rizzo L, et al. Semi-quantitative analysis of the histopathological features of the neuropathic foot ulcer: effects of pressure relief. Diabetes Care 2003; 26: 3123-3128.
17. Armstrong DG, Lavery LA, Kimtriel HR, Nixon BP, Boulton AJM. Activity patterns of patients with diabetic foot ulceration: patients with active ulcers may not adhere to standard pressure offloading regimens. Diabetes Care 2003; 26: 2595-2597.
18. Katz I, Harlan A, Miranda-Palma B, et al. A randomised trial of two irremovable offloading devices in the management of plantar neuropathic foot ulcers. Diabetologia 2004; 47(suppl 1):A4.
19. Badiavas EU, Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 2003; 138: 1079-1081.
20. Jeffcoate WJ. Vascular calcification and osteolysis in diabetic neuropathy—is RANK-L the missing link? Diabetologia 2004 (in press).
21. Jude EB, Selby PL, Burgess J, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a randomized controlled trial. Diabetologia 2001; 44: 2032-2037.
22. Valk GD, Kriegsman DH, Assendelft WJ. Patient education for preventing diabetic foot ulceration: a systematic review. Endocrinol Metab Clin North Am 2002; 31: 633-658.
23. Cavanagh PR. Can therapeutic footwear help protect the insensate diabetic foot? Int Diabet Monitor 2004; 16(4):10-16.